Patents Assigned to Lipideon Biotechnology AG
  • Patent number: 9212175
    Abstract: The present invention relates to novel azetidinone-containing compounds having a novel side-chain which is attached to the aryl ring at C4 via a C—C bond and comprises a 3,3-disubstituted oxetane ring and a polar group A, and which are useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: December 15, 2015
    Assignee: Lipideon Biotechnology AG
    Inventors: Thomas Fessard, Dong-Bo Li, Damien Barbaras, Susanne Wolfrum, Erick Carreira
  • Publication number: 20120065168
    Abstract: The present invention relates to novel azetidinone-containing compounds having a novel side-chain which is attached to the aryl ring at C4 via a C—C bond and comprises a 3,3-disubstituted oxetane ring and a polar group A, and which are useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels.
    Type: Application
    Filed: March 5, 2010
    Publication date: March 15, 2012
    Applicant: LIPIDEON BIOTECHNOLOGY AG
    Inventors: Thomas Fessard, Dong-Bo Li, Damien Barbaras, Susanne Wolfrum, Erick Carreira
  • Patent number: 7544667
    Abstract: The present invention relates to novel hypocholesterolemic compounds of formula (I) useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprising said compounds alone or in combination with other active agents.
    Type: Grant
    Filed: September 15, 2004
    Date of Patent: June 9, 2009
    Assignee: Lipideon Biotechnology AG
    Inventors: Erick Carreira, Helmut Hauser, Lisbet Kvaerno, Tobias Ritter, Moritz Werder